Not yet another negative trial-ReACTing on recent glioblastoma trials
The present ReACT trial provides data from a small randomized controlled vaccination trial that in addition to other recent immunotherapy trials in glioblastoma allows sketching a rational, advanced trial design for the development of (immune) therapies in glioblastoma elaborating on but not restric...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
April 2020
|
| In: |
Clinical cancer research
Year: 2020, Jahrgang: 26, Heft: 7, Pages: 1535-1537 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-19-4032 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-19-4032 Verlag, lizenzpflichtig, Volltext: https://clincancerres.aacrjournals.org/content/26/7/1535 
|
| Verfasserangaben: | Wolfgang Wick and Robin J. Wagener |
| Zusammenfassung: | The present ReACT trial provides data from a small randomized controlled vaccination trial that in addition to other recent immunotherapy trials in glioblastoma allows sketching a rational, advanced trial design for the development of (immune) therapies in glioblastoma elaborating on but not restricting to biological monitoring and endpoints.See related article by Reardon et al., p. 1586 |
|---|---|
| Beschreibung: | Gesehen am 20.04.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-19-4032 |